Pediatric Open-Label Extension Study of Etanercept in Patients With Plaque Psoriasis

NCT00141921 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

182

Enrollment

INDUSTRY

Sponsor class

Conditions

Pediatric Plaque Psoriasis

Interventions

DRUG: Etanercept

Sponsor

Amgen